AMANDA NICHOLAS: Open Payments
NPI 1689452013 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,210 in 61 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,290 · 2025 $1,210
Food & beverage: $1,210
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $241 |
| AstraZeneca Pharmaceuticals LP | 8 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $119 |
| GlaxoSmithKline, LLC. | 6 | $102 |
| Exact Sciences Corporation | 5 | $93 |
| Madrigal Pharmaceuticals | 2 | $74 |
| Novo Nordisk Inc | 3 | $55 |
| Insulet Corporation | 2 | $53 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
Products named: AIRSUPRA, CAPLYTA, UBRELVY, VRAYLAR, Cologuard Collection Kit, TRELEGY ELLIPTA, REZDIFFRA, JARDIANCE.
Industry payments across NY — which companies pay providers there.
